Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia

Journal of Reproductive Immunology

Volumn 101-102, Issue 1, 2014, Pages 153-160

  Ramma, Wenda ^a   Ahmed, Asif ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

Carbon monoxide (CO); Heme oxygenase 1 (Hmox1); Preeclampsia; Soluble Endoglin (sEng); Soluble Flt 1 (sFlt 1); Statins; Vascular endothelial growth factor (VEGF)

Indexed keywords

BILIRUBIN; CARBON MONOXIDE; ENDOGLIN; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; VASCULOTROPIN RECEPTOR 1;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; EXPIRED AIR; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MORBIDITY; NONHUMAN; PATHOGENESIS; PREECLAMPSIA; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; TROPHOBLAST;

CARBON MONOXIDE (CO); HEME OXYGENASE-1 (HMOX1); PREECLAMPSIA; SOLUBLE ENDOGLIN (SENG); SOLUBLE FLT-1 (SFLT-1); STATINS; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HEME OXYGENASE-1; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84897673455     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2013.12.120     Document Type: Article

References (83)

1. Acevedo C.H., Ahmed A. Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy. J. Clin. Invest. 1998, 101:949-955.
2. Ahmad S., Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ. Res. 2004, 95:884-891.
3. Ahmed A., Williams D. Statins to Ameliorate early onset Pre-eclampsia: a proof of principle, double-blind, randomised placebo-controlled, multicentre trial of pravastatin to ameliorate early onset pre-eclampsia. 2009, 10.1186/ISRCTN23410175.
4. Ahmed A. Heparin-binding angiogenic growth factors in pregnancy. Trophoblast Res. 1997, 10:215-258.
5. Ahmed A. New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications. Thromb. Res. 2011, 127S3:S72-S75.
6. Ahmed A., Li X.F., Dunk C., Whittle M.J., Rushton D.I., Rollason T. Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 1995, 12:235-243.
7. Ahmed A., Rahman M., Zhang X., Acevedo C.H., Nijjar S., Rushton I., Bussolati B., St John J. Induction of placental heme oxygenase-1 is protective against TNFalpha- induced cytotoxicity and promotes vessel relaxation. Mol. Med. 2000, 6:391-409.
8. Ahmed H., Mclaughlin B.E., Soong J., Marks G.S., Brien J.F., Nakatsu K. The source of endogenous carbon monoxide formation in human placental chorionic villi. Cell Mol. Biol. (Noisy-le-grand) 2005, 51:447-451.
9. Alexandreanu I.C., Lawson D.M. Effects of chronic administration of a heme oxygenase substrate or inhibitor on progression of the estrous cycle, pregnancy and lactation of Sprague-Dawley rats. Life Sci. 2002, 72:153-162.
10. Bauer A.J., Banek C.T., Needham K., Gillham H., Capoccia S., Regal J.F., Gilbert J.S. Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension. Hypertension 2013, 61:1103-1110.
11. Baum M., Schiff E., Kreiser D., Dennery P.A., Stevenson D.K., Rosenthal T., Seidman D.S. End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am. J. Obstet. Gynecol. 2000, 183:900-903.
12. Bergmann A., Ahmad S., Cudmore M., Gruber A.D., Wittschen P., Lindenmaier W., Christofori G., Gross V., Gonzalves A., Grone H.J., Ahmed A., Weich H.A. Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J. Cell. Mol. Med. 2010, 14:1857-1867.
13. Breslin E., Kaufmann A., Quenby S. Bilirubin influences the clinical presentation of pre-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013, 170:111-113.
14. Charnock-Jones D.S., Sharkey A.M., Boocock C.A., Ahmed A., Plevin R., Ferrara N., Smith S.K. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol. Reprod. 1994, 51:524-530.
15. Conde-Agudelo A., Althabe F., Belizan J.M., Kafury-Goeta A.C. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am. J. Obstet. Gynecol. 1999, 181:1026-1035.
16. Costantine M.M., Tamayo E., Lu F., Bytautiene E., Longo M., Hankins G.D., Saade G.R. Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia. Obstet. Gynecol. 2010, 116:114-120.
17. Cudmore M., Ahmad S., Al-Ani B., Fujisawa T., Coxall H., Chudasama K., Devey L.R., Wigmore S.J., Abbas A., Hewett P.W., Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 2007, 115:1789-1797.
18. Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007, 115:1285-1295.
19. Djurovic S., Clausen T., Wergeland R., Brosstad F., Berg K., Henriksen T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG 2002, 109:759-764.
20. Dulak J., Deshane J., Jozkowicz A., Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 2008, 117:231-241.
21. Dunk C., Ahmed A. Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast. Histol. Histopathol. 2001, 16:359-375.
22. Edison R.J., Muenke M. Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am. J. Med. Genet. A 2004, 131:287-298.
23. Farina A., Sekizawa A., De Sanctis P., Purwosunu Y., Okai T., Cha D.H., Kang J.H., Vicenzi C., Tempesta A., Wibowo N., Valvassori L., Rizzo N. Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. Prenat. Diagn. 2008, 28:956-961.
24. Fox K.A., Longo M., Tamayo E., Kechichian T., Bytautiene E., Hankins G.D., Saade G.R., Costantine M.M. Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia. AJR Am. J. Obstet. Gynecol. 2011, 205. 366 e1-5.
25. George E.M., Arany I. Induction of heme oxygenase-1 shifts the balance from proinjury to prosurvival in the placentas of pregnant rats with reduced uterine perfusion pressure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302:R620-R626.
26. George E.M., Cockrell K., Aranay M., Csongradi E., Stec D.E., Granger J.P. Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension 2011, 57:941-948.
27. George E.M., Hosick P.A., Stec D.E., Granger J.P. Heme oxygenase inhibition increases blood pressure in pregnant rats. Am. J. Hypertens. 2013, 26:924-930.
28. Gilbert J.S., Gilbert S.A., Arany M., Granger J.P. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 2009, 53:399-403.
29. Goldstein J.L., Brown M.S. The LDL receptor. Arterioscler. Thromb. Vasc. Biol. 2009, 29:431-438.
30. Haendeler J., Hoffmann J., Zeiher A.M., Dimmeler S. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Circulation 2004, 110:856-861.
31. Hatanaka T. Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events. Clin. Pharmacokinet. 2000, 39:397-412.
32. Ihara N., Akagi R., Ejiri K., Kudo T., Furuyama K., Fujita H. Developmental changes of gene expression in heme metabolic enzymes in rat placenta. FEBS Lett. 1998, 439:163-167.
33. Kazmin A., Garcia-Bournissen F., Koren G. Risks of statin use during pregnancy: a systematic review. J. Obstet. Gynaecol. Can. 2007, 29:906-908.
34. Khaliq A., Li X.F., Shams M., Sisi P., Acevedo C.A., Whittle M.J., Weich H., Ahmed A. Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors 1996, 13:243-250.
35. Khaliq A., Dunk C., Jiang J., Shams M., Li X.F., Acevedo C., Weich H., Whittle M., Ahmed A. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction. Lab. Invest. 1999, 79:151-170.
36. Kilby M.D., Afford S., Li X.F., Strain A.J., Ahmed A., Whittle M.J. Localisation of hepatocyte growth factor and its receptor (c-met) protein and mRNA in human term placenta. Growth Factors 1996, 13:133-139.
37. Kreiser D., Baum M., Seidman D.S., Fanaroff A., Shah D., Hendler I., Stevenson D.K., Schiff E., Druzin M.L. End tidal carbon monoxide levels are lower in women with gestational hypertension and pre-eclampsia. J. Perinatol. 2004, 24:213-217.
38. Kronborg C.S., Gjedsted J., Vittinghus E., Hansen T.K., Allen J., Knudsen U.B. Longitudinal measurement of cytokines in pre-eclamptic and normotensive pregnancies. Acta Obstet. Gynecol. Scand. 2011, 90:791-796.
39. Kumasawa K., Ikawa M., Kidoya H., Hasuwa H., Saito-Fujita T., Morioka Y., Takakura N., Kimura T., Okabe M. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:1451-1455.
40. Landmesser U., Bahlmann F., Mueller M., Spiekermann S., Kirchhoff N., Schulz S., Manes C., Fischer D., De Groot K., Fliser D., Fauler G., Marz W., Drexler H. Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans. Circulation 2005, 111:2356-2363.
41. Lash G.E., Mclaughlin B.E., Macdonald-Goodfellow S.K., Smith G.N., Brien J.F., Marks G.S., Nakatsu K., Graham C.H. Relationship between tissue damage and heme oxygenase expression in chorionic villi of term human placenta. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H160-H167.
42. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., Schisterman E.F., Thadhani R., Sachs B.P., Epstein F.H., Sibai B.M., Sukhatme V.P., Karumanchi S.A. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004, 350:672-683.
43. Levine R.J., Thadhani R., Qian C., Lam C., Lim K.H., Yu K.F., Blink A.L., Sachs B.P., Epstein F.H., Sibai B.M., Sukhatme V.P., Karumanchi S.A. Urinary placental growth factor and risk of preeclampsia. JAMA 2005, 293:77-85.
44. Levine R.J., Lam C., Qian C., Yu K.F., Maynard S.E., Sachs B.P., Sibai B.M., Epstein F.H., Romero R., Thadhani R., Karumanchi S.A. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 2006, 355:992-1005.
45. Ludman A., Venugopal V., Yellon D.M., Hausenloy D.J. Statins and cardioprotection-more than just lipid lowering?. Pharmacol. Ther. 2009, 122:30-43.
46. Maines M.D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988, 2:2557-2568.
47. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., Libermann T.A., Morgan J.P., Sellke F.W., Stillman I.E., Epstein F.H., Sukhatme V.P., Karumanchi S.A. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 2003, 111:649-658.
48. McCarthy F.P., Drewlo S., Kingdom J., Johns E.J., Walsh S.K., Kenny L.C. Peroxisome proliferator-activated receptor-gamma as a potential therapeutic target in the treatment of preeclampsia. Hypertension 2011, 58:280-286.
49. McLean M., Bowman M., Clifton V., Smith R., Grossman A.B. Expression of the heme oxygenase-carbon monoxide signalling system in human placenta. J. Clin. Endocrinol. Metab. 2000, 85:2345-2349.
50. McTaggart F., Buckett L., Davidson R., Holdgate G., Mccormick A., Schneck D., Smith G., Warwick M. Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Am. J. Cardiol. 2001, 87:28B-32B.
51. Mehendale R., Hibbard J., Fazleabas A., Leach R. Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke. Am. J. Obstet. Gynecol. 2007, 197:363 e1-5.
52. Miyagami S., Koide K., Sekizawa A., Ventura W., Yotsumoto J., Oishi S., Okai T. Physiological changes in the pattern of placental gene expression early in the first trimester. Reprod. Sci. 2013, 20:710-714.
53. Molcanyiova A., Stancakova A., Javorsky M., Tkac I. Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia. Pharmacol. Res. 2006, 54:203-207.
54. Motterlini R., Foresti R., Vandegriff K., Intaglietta M., Winslow R.M. Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. Am. J. Physiol. 1995, 269:H648-H655.
55. Muchova L., Wong R.J., Hsu M., Morioka I., Vitek L., Zelenka J., Schroder H., Stevenson D.K. Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection. Can. J. Physiol. Pharmacol. 2007, 85:800-810.
56. Murphy B.J., Laderoute K.R., Short S.M., Sutherland R.M. The identification of heme oxygenase as a major hypoxic stress protein in Chinese hamster ovary cells. Br. J. Cancer 1991, 64:69-73.
57. Ofori B., Rey E., Berard A. Risk of congenital anomalies in pregnant users of statin drugs. Br. J. Clin. Pharmacol. 2007, 64:496-509.
58. Ozler A., Turgut A., Sak M.E., Evsen M.S., Soydinc H.E., Evliyaoglu O., Gul T. Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity. Eur. Rev. Med. Pharmacol. Sci. 2012, 16:1707-1712.
59. Ramma W., Ahmed A. Is inflammation the cause of pre-eclampsia?. Biochem. Soc. Trans. 2011, 39:1619-1627.
60. Ramma W., Buhimschi I.A., Zhao G., Dulay A.T., Nayeri U.A., Buhimschi C.S., Ahmed A. The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia. Angiogenesis 2012, 15:333-340.
61. Redecha P., Van Rooijen N., Torry D., Girardi G. Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood 2009, 113:4101-4109.
62. Redman C.W., Sacks G.P., Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 1999, 180:499-506.
63. Roberts J.M., Redman C.W. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993, 341:1447-1451.
64. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., Mclaughlin M.K. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 1989, 161:1200-1204.
65. Saad A.F., Kechichian T., Yin H., Sbrana E., Longo M., Wen M., Tamayo E., Hankins G.D., Saade G.R., Costantine M.M. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia. Reprod. Sci. 2014, 21:138-145.
66. Sharkey A.M., Charnock-Jones D.S., Boocock C.A., Brown K.D., Smith S.K. Expression of mRNA for vascular endothelial growth factor in human placenta. J. Reprod. Fertil. 1993, 99:609-615.
67. Sidle E.H., Casselman R., Smith G.N. Effect of cigarette smoke on placental antioxidant enzyme expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R754-R758.
68. Sikorski E.M., Hock T., Hill-Kapturczak N., Agarwal A. The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury. Am. J. Physiol. Renal Physiol. 2004, 286:F425-F441.
69. Tenhunen R., Marver H.S., Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J. Biol. Chem. 1969, 244:6388-6394.
70. Thadhani R., Kisner T., Hagmann H., Bossung V., Noack S., Schaarschmidt W., Jank A., Kribs A., Cornely O.A., Kreyssig C., Hemphill L., Rigby A.C., Khedkar S., Lindner T.H., Mallmann P., Stepan H., Karumanchi S.A., Benzing T. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 2011, 124:940-950.
71. Urbich C., Dimmeler S. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int. 2005, 67:1672-1676.
72. Venkatesha S., Toporsian M., Lam C., Hanai J., Mammoto T., Kim Y.M., Bdolah Y., Lim K.H., Yuan H.T., Libermann T.A., Stillman I.E., Roberts D., D'Amore P.A., Epstein F.H., Sellke F.W., Romero R., Sukhatme V.P., Letarte M., Karumanchi S.A. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 2006, 12:642-649.
73. Wang K., Ahmad S., Cai M., Rennie J., Fujisawa T., Crispi F., Baily J., Miller M.R., Cudmore M., Hadoke P.W., Wang R., Gratacos E., Buhimschi I.A., Buhimschi C.S., Ahmed A. Dysregulation of hydrogen sulfide producing enzyme cystathionine gamma-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation 2013, 127:2514-2522.
74. Weis M., Heeschen C., Glassford A.J., Cooke J.P. Statins have biphasic effects on angiogenesis. Circulation 2002, 105:739-745.
75. Woollett L.A. Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation. Am. J. Clin. Nutr. 2005, 82:1155-1161.
76. Woollett L.A. Review: transport of maternal cholesterol to the fetal circulation. Placenta 2011, 32(Suppl. 2):S218-S221.
77. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., Ohta K., Kasahara Y., Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 1999, 103:129-135.
78. Yoshiki N., Kubota T., Aso T. Expression and localization of heme oxygenase in human placental villi. Biochem. Biophys. Res. Commun. 2000, 276:1136-1142.
79. Zenclussen A.C., Fest S., Joachim R., Klapp B.F., Arck P.C. Introducing a mouse model for pre-eclampsia: adoptive transfer of activated Th1 cells leads to pre-eclampsia-like symptoms exclusively in pregnant mice. Eur. J. Immunol. 2004, 34:377-387.
80. Zenclussen M.L., Anegon I., Bertoja A.Z., Chauveau C., Vogt K., Gerlof K., Sollwedel A., Volk H.D., Ritter T., Zenclussen A.C. Over-expression of heme oxygenase-1 by adenoviral gene transfer improves pregnancy outcome in a murine model of abortion. J. Reprod. Immunol. 2006, 69:35-52.
81. Zhao H., Wong R.J., Kalish F.S., Nayak N.R., Stevenson D.K. Effect of heme oxygenase-1 deficiency on placental development. Placenta 2009, 30:861-868.
82. Zhou C.C., Irani R.A., Zhang Y., Blackwell S.C., Mi T., Wen J., Shelat H., Geng Y.J., Ramin S.M., Kellems R.E., Xia Y. Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia. Circulation 2010, 121:436-444.
83. Zhao H., Azuma J., Kalish F., Wong R.J., Stevenson D.K. Maternal heme oxygenase 1 regulates placental vasculature development via angiogenic factors in mice. Biol Reprod. 2011, 85(5):1005-1012.